Company registration number 12965206 (England and Wales)
MERAKI HEALING LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
PAGES FOR FILING WITH REGISTRAR
MERAKI HEALING LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
MERAKI HEALING LIMITED
BALANCE SHEET
AS AT
31 OCTOBER 2025
31 October 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
5,360
5,975
Current assets
Debtors
28,952
28,579
Cash at bank and in hand
1,842
2,525
30,794
31,104
Creditors: amounts falling due within one year
4
(157,212)
(156,548)
Net current liabilities
(126,418)
(125,444)
Net liabilities
(121,058)
(119,469)
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
(121,158)
(119,569)
Total equity
(121,058)
(119,469)

For the financial year ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 10 July 2026 and are signed on its behalf by:
Mrs A Atkinson
Director
Company registration number 12965206 (England and Wales)
MERAKI HEALING LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
- 2 -
1
Accounting policies
Company information

Meraki Healing Limited is a private company limited by shares incorporated in England and Wales. The registered office is Moorgate House, King Street, Newton Abbot, Devon, TQ12 2LG.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

The financial statements have been prepared on a going concern basis, as the company continues to have the support of its directors.true

A t the time of approving the financial statements, t he directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business. Turnover is recognised when services are provided.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
10% reducing balance
Computers
33.33% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

MERAKI HEALING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
1
Accounting policies
(Continued)
- 3 -
1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
MERAKI HEALING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
- 4 -
3
Tangible fixed assets
Plant and equipment
Computers
Total
£
£
£
Cost
At 1 November 2024 and 31 October 2025
9,078
2,538
11,616
Depreciation and impairment
At 1 November 2024
3,122
2,519
5,641
Depreciation charged in the year
596
19
615
At 31 October 2025
3,718
2,538
6,256
Carrying amount
At 31 October 2025
5,360
-
0
5,360
At 31 October 2024
5,956
19
5,975
4
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
13
13
Other creditors
157,199
156,535
157,212
156,548
5
Related party transactions
2025
2024
Amounts due to related parties
£
£
Key management personnel
140,682
155,585
2025-10-31 2024-11-01 false false false 10 July 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Mrs A Atkinson Mrs L J S Bridle 12965206 2024-11-01 2025-10-31 12965206 2025-10-31 12965206 2024-10-31 12965206 core:PlantMachinery 2025-10-31 12965206 core:ComputerEquipment 2025-10-31 12965206 core:PlantMachinery 2024-10-31 12965206 core:ComputerEquipment 2024-10-31 12965206 core:CurrentFinancialInstruments core:WithinOneYear 2025-10-31 12965206 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 12965206 core:CurrentFinancialInstruments 2025-10-31 12965206 core:CurrentFinancialInstruments 2024-10-31 12965206 core:ShareCapital 2025-10-31 12965206 core:ShareCapital 2024-10-31 12965206 core:RetainedEarningsAccumulatedLosses 2025-10-31 12965206 core:RetainedEarningsAccumulatedLosses 2024-10-31 12965206 bus:Director1 2024-11-01 2025-10-31 12965206 core:PlantMachinery 2024-11-01 2025-10-31 12965206 core:ComputerEquipment 2024-11-01 2025-10-31 12965206 2023-11-01 2024-10-31 12965206 core:PlantMachinery 2024-10-31 12965206 core:ComputerEquipment 2024-10-31 12965206 2024-10-31 12965206 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 12965206 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 12965206 bus:FRS102 2024-11-01 2025-10-31 12965206 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 12965206 bus:Director2 2024-11-01 2025-10-31 12965206 bus:FullAccounts 2024-11-01 2025-10-31 xbrli:pure xbrli:shares iso4217:GBP